Cochlear | COH - Fremdkapital





Fremdkapital Veränderung Datum
Ansell USD 751.6M 113.1M 2025-12
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Fisher Paykel Healthcare NZD 62.6M 4.3M 2025-12
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Mayne Pharma AUD 2.66M 153K 2025-06
Mesoblast USD 66.02M 1.72M 2025-12
Monash IVF AUD 186.73M 16.17M 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Polynovo AUD 15.39M 663K 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
Regis Healthcare AUD 3.24M 435K 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sigma Healthcare AUD 1.88B 1.75B 2025-12
Somnomed AUD 20.94M 257.07K 2023-06
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12